OCEA Ocean Biomedical, Inc. Sotuvning sof marjinal rentabelligi

Ocean Biomedical Inc (OCEA) korporativ emblemasi va logotipi

Ocean Biomedical, Inc. (OCEA) universitet patentlarini tijoratlashtirish sohasida faoliyat yuritadi, bu yerda bozorga kirish FDA talablari bilan cheklangan. Umumiy sof marja ushbu jarayon dinamikasini kuzatishga yordam beradi, bunda 0.00 joriy metrika darajasi vazifasini o'taydi. Biznes bezak qarshi vaksinalar va onkologik dori vositalarini ishlab chiqish uchun grantlarga tayanadi. Klinikadan oldingi tadqiqotlar YaIM sikllaridan mustaqil qolmoqda, bu esa makroiqtisodiy tebranishlarga yuqori chidamlilikni namoyish etadi.

Ocean Biomedical, Inc. (OCEA) - Sotuvning sof marjinal rentabelligi 28.04.2023dan 24.05.2025gacha

Ocean Bio (OCEA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Fundamental baholash:Ocean Biomedical Inc - OCEA
Ocean Biomedical Inc tayyor mahsulotlari

Ocean Biomedical, Inc. (OCEA) uchun umumiy sof foyda marjasi daromadlarining onkologiya va bezgak tadqiqotlarining muvaffaqiyatiga bog'liqligini aks ettiradi. Ushbu ko'rsatkich sof foydaning umumiy daromadga nisbati sifatida hisoblanadi va daromadning yakuniy kapitalga aylanish samaradorligini o'lchaydi. Ushbu metrikaning tendentsiyasi biznesning bozor signallariga va litsenziyalash kelishuvlariga bo'lgan reaksiyasini ifodalaydi. Manfiy qiymatlar operatsion xarajatlarni qoplash uchun tashqi moliyalashtirishga bo'lgan ehtiyojni ta'kidlaydi. Ushbu ko'rsatkichning barqaror o'sishi biznes modelining fundamental barqarorligini tasdiqlaydi.

Ocean Biomedical, Inc. (OCEA) raqobatchilari

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Sof foyda normasi|Adicet Bio, Inc. - Sotuvning sof rentabelligi|Celularity Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi INmune Bio Corporation INMB|Barinthus Biotherapeutics - Sotuvning sof marjinal rentabelligi|Kezar Life Sciences, Inc. (KZR) - Sof foyda bo'yicha sotuv rentabelligi|SAB Biotherapeutics Inc. (SABS) - Sof marja|Sof foyda bo'yicha sotuv rentabelligi Akari Therapeutics plc|Sof marja enlivex.com|q32bio.com (QTTB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi GOVX|Edesa Biotech, Inc. - Sotuvning sof rentabelligi|iBio Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Carisma Therapeutics CARM|XTLB - Sof marja|BOLT (boltbio.com) - Sotuvning sof rentabelligi|HCWB: Sotuvning sof marjinal rentabelligi|Aptevo (APVO) - Sotuvning sof marjinal rentabelligi|Sof marja AIM ImmunoTech|Sof foyda bo'yicha sotuv rentabelligi Aditxt (ADTX)|Sof foyda bo'yicha sotuv rentabelligi GRI (GRI Bio Corporation)|XORTX - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi HIND (Vyome Holdings Inc.)|Sof foyda normasi REVB|Indaptus - Sotuvning sof marjinal rentabelligi|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning sof rentabelligi|CALI: Sotuvning sof marjinal rentabelligi|Affimed NV - Sof foyda normasi|Sof marja Allakos Inc.|Sotuvning sof marjinal rentabelligi HOOKIPA Pharma|Sof marja IGM Biosciences, Inc. (IGMS)|ITOS - Sof marja|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi